Evidence map›Paper›PMID 41807282›Full record

ArticlePigment cell & melanoma research2026

A Short Report on Melanocyte/Melanoma Culture, Senescence, and Reproducibility.

Lionel Larue, ESPCR Working Group, Duarte C Barral, Veronique Delmas, Sara Egea-Rodriguez, Daniel Aldea, Heather C Etchevers, Marie-Dominique Galibert, Robert N Kelsh, Luisa Lanfrancone and 4 more

Abstract read
In one paragraph

Article in Pigment cell & melanoma research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lionel LarueINSERM U1021, Normal and Pathological Development of Melanocytes, Institut Curie, PSL Research University, Orsay, France.
ESPCR Working Group
Duarte C BarraliNOVA4Health, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisboa, Portugal.ORCID 0000-0001-8867-2407
Veronique DelmasINSERM U1021, Normal and Pathological Development of Melanocytes, Institut Curie, PSL Research University, Orsay, France.
Sara Egea-RodriguezDepartment of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
Daniel AldeaINSERM, Marseille Medical Genetics, U1251, Institut MarMaRa, Aix Marseille University, Marseille, France.
Heather C EtcheversINSERM, Marseille Medical Genetics, U1251, Institut MarMaRa, Aix Marseille University, Marseille, France.ORCID 0000-0003-0201-3799
Marie-Dominique GalibertDepartment of Molecular Genetics and Genomics, CNRS, INSERM, IGDR (Institut de Génétique et Développement de Rennes)-UMR6290, ERL U1305-Hospital University of Rennes, Univ. Rennes, Rennes, France.
Robert N KelshDepartment of Life Sciences, University of Bath, Bath, UK.
Luisa LanfranconeDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0002-4523-3815
Michele MadiganOptometry and Vision Science, UNSW Sydney, Sydney, Australia.ORCID 0000-0003-1053-6979
Pedro Moura-Alvesi3S, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Richard M WhiteLudwig Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Anja BosserhoffInstitute of Biochemistry, FAU Erlangen-Nürnberg, Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At the 2025 ESPCR (European Society for Pigment Cell Research) meeting in Erlangen, a workshop on "Pigment Cell Models: Sensitivity, Innovation, and the Challenges of Cell Culture" brought together researchers to discuss technical, methodological, and reproducibility issues in culturing melanocytes, keratinocytes, fibroblasts, and melanoma cells. The discussion between experts in the field highlighted key and recurrent pitfalls affecting experimental outcomes, including low-density seeding, temperature fluctuations, over-passaging, and mycoplasma contamination, as well as sources of variability arising from media composition, batch effects, and environmental conditions. Importantly, the workshop distinguished between practices supported by evidence and consensus-based guidance derived from collective expert experience. Species- and donor-specific differences, especially between human, mouse, and zebrafish melanocyte models, were identified as additional major determinants of experimental variability. Emerging systems, including human and mouse pluripotent stem cell (PSC)-derived melanocytes, as well as avian and zebrafish melanoma lines, were discussed for their complementary mechanistic and translational value. Overall, the workshop concluded that transparent documentation, explicit reporting standards, and shared best practices are essential to improve reproducibility and further advance pigment cell research.

Indexed as

Cell Culture TechniquesCellular SenescenceMelanocytesMelanomaAnimalsHumansMiceReproducibility of ResultsZebrafish

Identifiers

PMID41807282
PMCPMC12975704

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.